- Home
- VYGR vs PAYS Comparison
VYGR vs PAYS Comparison
Compare VYGR & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- PAYS
- Stock Information
- Founded
- VYGR 2013
- PAYS 2001
- Country
- VYGR United States
- PAYS United States
- Employees
- VYGR N/A
- PAYS N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- PAYS Business Services
- Sector
- VYGR Health Care
- PAYS Consumer Discretionary
- Exchange
- VYGR Nasdaq
- PAYS Nasdaq
- Market Cap
- VYGR 156.0M
- PAYS 125.2M
- IPO Year
- VYGR 2015
- PAYS 1998
- Fundamental
- Price
- VYGR $2.97
- PAYS $5.45
- Analyst Decision
- VYGR Strong Buy
- PAYS Strong Buy
- Analyst Count
- VYGR 8
- PAYS 4
- Target Price
- VYGR $14.33
- PAYS $6.56
- AVG Volume (30 Days)
- VYGR 841.7K
- PAYS 482.1K
- Earning Date
- VYGR 08-05-2025
- PAYS 07-30-2025
- Dividend Yield
- VYGR N/A
- PAYS N/A
- EPS Growth
- VYGR N/A
- PAYS N/A
- EPS
- VYGR N/A
- PAYS 0.11
- Revenue
- VYGR $66,958,000.00
- PAYS $63,792,627.00
- Revenue This Year
- VYGR N/A
- PAYS $30.03
- Revenue Next Year
- VYGR $78.88
- PAYS $20.14
- P/E Ratio
- VYGR N/A
- PAYS $50.02
- Revenue Growth
- VYGR N/A
- PAYS 26.77
- 52 Week Low
- VYGR $2.65
- PAYS $1.80
- 52 Week High
- VYGR $9.55
- PAYS $5.59
- Technical
- Relative Strength Index (RSI)
- VYGR 41.86
- PAYS 77.72
- Support Level
- VYGR $3.24
- PAYS $4.72
- Resistance Level
- VYGR $3.64
- PAYS $5.10
- Average True Range (ATR)
- VYGR 0.27
- PAYS 0.27
- MACD
- VYGR -0.02
- PAYS 0.00
- Stochastic Oscillator
- VYGR 6.17
- PAYS 91.18
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.